Top Markets
Coin of the day
Emcure Pharmaceuticals Ltd. Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Ltd.

EMCURE
Rank in Stocks #4304
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Share Price
$20.55
Market Cap
$3.90B
Change (1 day)
0.83%
Change (1 year)
22.65%
Country
IN
Trade Emcure Pharmaceuticals Ltd. (EMCURE)

Category

Dividend history for Emcure Pharmaceuticals Ltd. (EMCURE)
Emcure Pharmaceuticals Ltd. (stock symbol: EMCURE) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Emcure Pharmaceuticals Ltd. (EMCURE) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors